Moschel RC - Search Results

1

Role of GADD34 in modulation of cisplatin cytotoxicity.

Fishel ML, Rabik CA, Bleibel WK, Li X, Moschel RC, Dolan ME. Fishel ML, et al. Among authors: moschel rc. Biochem Pharmacol. 2006 Jan 12;71(3):239-47. doi: 10.1016/j.bcp.2005.10.039. Epub 2005 Dec 1. Biochem Pharmacol. 2006. PMID: 16325149

2

Enhancement of platinum-induced cytotoxicity by O6-benzylguanine.

Fishel ML, Delaney SM, Friesen LD, Hansen RJ, Zuhowski EG, Moschel RC, Egorin MJ, Dolan ME. Fishel ML, et al. Among authors: moschel rc. Mol Cancer Ther. 2003 Jul;2(7):633-40. Mol Cancer Ther. 2003. PMID: 12883036

3

Effect of cell cycle inhibition on Cisplatin-induced cytotoxicity.

Fishel ML, Newell DR, Griffin RJ, Davison R, Wang LZ, Curtin NJ, Zuhowski EG, Kasza K, Egorin MJ, Moschel RC, Dolan ME. Fishel ML, et al. Among authors: moschel rc. J Pharmacol Exp Ther. 2005 Jan;312(1):206-13. doi: 10.1124/jpet.104.073924. Epub 2004 Aug 10. J Pharmacol Exp Ther. 2005. PMID: 15304523

4

Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O6-benzylguanine.

Fishel ML, Gamcsik MP, Delaney SM, Zuhowski EG, Maher VM, Karrison T, Moschel RC, Egorin MJ, Dolan ME. Fishel ML, et al. Among authors: moschel rc. Cancer Chemother Pharmacol. 2005 Apr;55(4):333-342. doi: 10.1007/s00280-004-0901-3. Epub 2004 Oct 2. Cancer Chemother Pharmacol. 2005. PMID: 15723259

5

Effect of O6-benzylguanine on the sensitivity of human colon tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).

Dolan ME, Pegg AE, Moschel RC, Grindey GB. Dolan ME, et al. Among authors: moschel rc. Biochem Pharmacol. 1993 Jul 20;46(2):285-90. doi: 10.1016/0006-2952(93)90416-t. Biochem Pharmacol. 1993. PMID: 8347150

6

Debenzylation of O(6)-benzyl-8-oxoguanine in human liver: implications for O(6)-benzylguanine metabolism.

Long L, Moschel RC, Dolan ME. Long L, et al. Among authors: moschel rc. Biochem Pharmacol. 2001 Mar 15;61(6):721-6. doi: 10.1016/s0006-2952(01)00523-8. Biochem Pharmacol. 2001. PMID: 11266657

7

Effect of O6-benzylguanine on the response to 1,3-bis(2-chloroethyl)-1-nitrosourea in the Dunning R3327G model of prostatic cancer.

Dolan ME, Pegg AE, Biser ND, Moschel RC, English HF. Dolan ME, et al. Among authors: moschel rc. Cancer Chemother Pharmacol. 1993;32(3):221-5. doi: 10.1007/BF00685839. Cancer Chemother Pharmacol. 1993. PMID: 8500228

8

O6-alkylguanine-DNA alkyltransferase inactivation by ester prodrugs of O6-benzylguanine derivatives and their rate of hydrolysis by cellular esterases.

Dolan ME, Roy SK, Garbiras BJ, Helft P, Paras P, Chae MY, Moschel RC, Pegg AE. Dolan ME, et al. Among authors: moschel rc. Biochem Pharmacol. 1998 May 15;55(10):1701-9. doi: 10.1016/s0006-2952(98)00047-1. Biochem Pharmacol. 1998. PMID: 9634007

9

Inactivation of O6-alkylguanine-DNA alkyltransferase by 8-substituted O6-benzylguanine analogs in mice.

Ewesuedo RB, Wilson LR, Friedman HS, Moschel RC, Dolan ME. Ewesuedo RB, et al. Among authors: moschel rc. Cancer Chemother Pharmacol. 2001;47(1):63-9. doi: 10.1007/s002800000202. Cancer Chemother Pharmacol. 2001. PMID: 11221964

10

Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation.

Mitchell RB, Moschel RC, Dolan ME. Mitchell RB, et al. Among authors: moschel rc. Cancer Res. 1992 Mar 1;52(5):1171-5. Cancer Res. 1992. PMID: 1737376

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters